Water Quality in COEUR D'ALENE, ID (83814)
EPA violation data for public water systems serving ZIP code 83814.
385
Total Violations
29
Health-Based
356
Monitoring / Reporting
373
Resolved
What does this mean?
373 of 385 violations have been resolved. 29 are health-based violations, meaning contaminant levels exceeded federal safety limits. The remaining 356 are monitoring or reporting violations (missed testing deadlines or late paperwork — not necessarily a water quality issue). Not all violations mean your water is unsafe. The EPA requires reporting even for minor administrative issues.
Violations Detail (385 total)
| Contaminant | Category | MCL Limit | Measured | Date | Status | Health Effects |
|---|---|---|---|---|---|---|
| E. COLI | Monitoring | 0 | N/A | Sep 20, 2025 | Active | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Public Notice | Monitoring | N/A | N/A | Aug 1, 2025 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.02 | Jun 30, 2025 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | May 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | May 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | May 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2025 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.019 | Mar 31, 2025 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.019 | Mar 31, 2025 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.019 | Mar 31, 2025 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 5, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 5, 2025 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Dec 31, 2024 | Active | N/A |
| TTHM | Monitoring | N/A | N/A | Dec 31, 2024 | Active | N/A |
| Arsenic | Health-Based | N/A | 0.017 | Dec 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.017 | Dec 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.017 | Dec 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | Dec 6, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 6, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2024 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.017 | Sep 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.017 | Sep 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.017 | Sep 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.015 | Jun 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Jun 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Jun 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| E. COLI | Monitoring | 0 | N/A | Jun 17, 2024 | Active | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Jun 17, 2024 | Active | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | May 1, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | May 1, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | May 1, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | May 1, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.015 | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2023 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.012 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2023 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 29, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 29, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 29, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Atrazine | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Cardiovascular system or reproductive problems |
| Atrazine | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Cardiovascular system or reproductive problems |
| Atrazine | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Cardiovascular system or reproductive problems |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Vinyl chloride | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Increased risk of cancer |
| Vinyl chloride | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Increased risk of cancer |
| Vinyl chloride | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Increased risk of cancer |
| Carbon tetrachloride | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Liver problems; increased risk of cancer |
| Carbon tetrachloride | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Liver problems; increased risk of cancer |
| Carbon tetrachloride | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Liver problems; increased risk of cancer |
| Trichloroethylene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Liver problems; increased risk of cancer |
| Trichloroethylene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Liver problems; increased risk of cancer |
| Trichloroethylene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Liver problems; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Radium-228 | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Increased risk of cancer |
| Radium-228 | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Increased risk of cancer |
| Radium-228 | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Increased risk of cancer |
| Radium-226 | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Increased risk of cancer |
| Radium-226 | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Increased risk of cancer |
| Radium-226 | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Increased risk of cancer |
| Endrin | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Diquat | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Diquat | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Diquat | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Endothall | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Endothall | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Endothall | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Glyphosate | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Glyphosate | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Glyphosate | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| 1,2-DIBROMO-3-CHLOROPROPANE | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| 1,2-DIBROMO-3-CHLOROPROPANE | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| 1,2-DIBROMO-3-CHLOROPROPANE | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Xylenes, Total | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Xylenes, Total | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Xylenes, Total | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 23, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 23, 2022 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 24, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 24, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Groundwater Rule | Monitoring | N/A | N/A | Apr 10, 2022 | Resolved | N/A |
| Groundwater Rule | Monitoring | N/A | N/A | Apr 10, 2022 | Resolved | N/A |
| Groundwater Rule | Monitoring | N/A | N/A | Apr 10, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2022 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 29, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 29, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 29, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 8, 2021 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 8, 2021 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 8, 2021 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Interim Enhanced Surface Water Treatment Rule | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Interim Enhanced Surface Water Treatment Rule | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 6, 2021 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 6, 2021 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 6, 2021 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Apr 7, 2021 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Apr 7, 2021 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Apr 7, 2021 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Apr 7, 2021 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 25, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 25, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 25, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2021 | Resolved | N/A |
Lead & Copper Levels
Violation Timeline
2025(24)
E. COLI
34
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Arsenic
02
Revised Total Coliform Rule
2D
Revised Total Coliform Rule
2D
Revised Total Coliform Rule
2D
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Arsenic
02
Arsenic
02
Arsenic
02
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
2024(43)
Total Haloacetic Acids (HAA5)
27
TTHM
27
Arsenic
02
Arsenic
02
Arsenic
02
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Arsenic
02
Arsenic
02
Arsenic
02
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3B
Revised Total Coliform Rule
3B
Arsenic
03
Arsenic
03
Arsenic
03
Arsenic
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Arsenic
02
Arsenic
02
Arsenic
02
E. COLI
34
E. COLI
34
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
2D
Revised Total Coliform Rule
2D
Revised Total Coliform Rule
2D
Revised Total Coliform Rule
2D
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
2023(51)
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Arsenic
02
Arsenic
02
Arsenic
02
Nitrate
03
Nitrate
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Arsenic
03
Arsenic
03
Arsenic
03
Arsenic
03
Arsenic
02
Arsenic
02
Arsenic
02
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Arsenic
03
Arsenic
03
Arsenic
03
Arsenic
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Arsenic
02
Arsenic
02
Arsenic
02
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
2022(207)
Arsenic
03
Arsenic
03
Arsenic
03
Arsenic
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Lead and Copper Rule
66
Lead and Copper Rule
66
Lead and Copper Rule
66
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Combined Uranium
03
Gross Alpha, Excl. Radon and U
03
LASSO
03
LASSO
03
LASSO
03
BHC-GAMMA
03
BHC-GAMMA
03
BHC-GAMMA
03
Combined Uranium
03
p-Dichlorobenzene
03
p-Dichlorobenzene
03
Atrazine
03
Atrazine
03
Atrazine
03
Di(2-ethylhexyl) adipate
03
Di(2-ethylhexyl) adipate
03
Di(2-ethylhexyl) adipate
03
Combined Uranium
03
trans-1,2-Dichloroethylene
03
trans-1,2-Dichloroethylene
03
trans-1,2-Dichloroethylene
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
DICHLOROMETHANE
03
Dinoseb
03
Dinoseb
03
Dinoseb
03
DICHLOROMETHANE
03
DICHLOROMETHANE
03
p-Dichlorobenzene
03
2,4-D
03
2,4-D
03
2,4-D
03
Methoxychlor
03
Methoxychlor
03
Methoxychlor
03
1,2,4-Trichlorobenzene
03
1,2,4-Trichlorobenzene
03
1,2,4-Trichlorobenzene
03
1,2-Dichloroethane
03
1,2-Dichloroethane
03
1,2-Dichloroethane
03
HEXACHLOROBENZENE
03
HEXACHLOROBENZENE
03
HEXACHLOROBENZENE
03
Dalapon
03
Dalapon
03
Dalapon
03
Vinyl chloride
03
Vinyl chloride
03
Vinyl chloride
03
Carbon tetrachloride
03
Carbon tetrachloride
03
Carbon tetrachloride
03
Trichloroethylene
03
Trichloroethylene
03
Trichloroethylene
03
Tetrachloroethylene
03
Tetrachloroethylene
03
Tetrachloroethylene
03
Benzene
03
Benzene
03
Benzene
03
Radium-228
03
Radium-228
03
Radium-228
03
Radium-226
03
Radium-226
03
Radium-226
03
Endrin
03
Endrin
03
Endrin
03
Toxaphene
03
Toxaphene
03
Toxaphene
03
Diquat
03
Diquat
03
Diquat
03
Endothall
03
Endothall
03
Endothall
03
Glyphosate
03
Glyphosate
03
Glyphosate
03
OXAMYL
03
OXAMYL
03
OXAMYL
03
Simazine
03
Simazine
03
Simazine
03
Di(2-ethylhexyl) phthalate
03
Di(2-ethylhexyl) phthalate
03
Di(2-ethylhexyl) phthalate
03
Picloram
03
Picloram
03
Picloram
03
Hexachlorocyclopentadiene
03
Hexachlorocyclopentadiene
03
Hexachlorocyclopentadiene
03
Carbofuran
03
Carbofuran
03
Carbofuran
03
Heptachlor epoxide
03
Heptachlor epoxide
03
Heptachlor epoxide
03
2,4,5-TP
03
2,4,5-TP
03
2,4,5-TP
03
Benzo(a)pyrene
03
Benzo(a)pyrene
03
Benzo(a)pyrene
03
Pentachlorophenol
03
Pentachlorophenol
03
Pentachlorophenol
03
1,2-DIBROMO-3-CHLOROPROPANE
03
1,2-DIBROMO-3-CHLOROPROPANE
03
1,2-DIBROMO-3-CHLOROPROPANE
03
ETHYLENE DIBROMIDE
03
ETHYLENE DIBROMIDE
03
ETHYLENE DIBROMIDE
03
Chlordane
03
Chlordane
03
Chlordane
03
cis-1,2-Dichloroethylene
03
cis-1,2-Dichloroethylene
03
cis-1,2-Dichloroethylene
03
Xylenes, Total
03
Xylenes, Total
03
Xylenes, Total
03
o-Dichlorobenzene
03
o-Dichlorobenzene
03
o-Dichlorobenzene
03
1,1,1-Trichloroethane
03
1,1,1-Trichloroethane
03
1,1,1-Trichloroethane
03
1,1,2-Trichloroethane
03
1,1,2-Trichloroethane
03
1,1,2-Trichloroethane
03
CHLOROBENZENE
03
CHLOROBENZENE
03
CHLOROBENZENE
03
Toluene
03
Ethylbenzene
03
Toluene
03
Toluene
03
Ethylbenzene
03
Ethylbenzene
03
Styrene
03
Styrene
03
Styrene
03
Total Polychlorinated Biphenyls (PCB)
03
Total Polychlorinated Biphenyls (PCB)
03
Total Polychlorinated Biphenyls (PCB)
03
1,2-Dichloropropane
03
1,2-Dichloropropane
03
1,2-Dichloropropane
03
Heptachlor
03
Heptachlor
03
Heptachlor
03
1,1-Dichloroethylene
03
1,1-Dichloroethylene
03
1,1-Dichloroethylene
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Arsenic
03
Arsenic
03
Arsenic
03
Arsenic
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Groundwater Rule
20
Groundwater Rule
20
Groundwater Rule
20
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
2021(60)
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Lead and Copper Rule
66
Lead and Copper Rule
66
Lead and Copper Rule
66
Public Notice
76
Public Notice
76
Public Notice
76
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Interim Enhanced Surface Water Treatment Rule
38
Interim Enhanced Surface Water Treatment Rule
38
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
76
Public Notice
76
Public Notice
76
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Consumer Confidence Rule
71
Chlorine
27
Chlorine
27
Chlorine
27
Chlorine
27
Consumer Confidence Rule
71
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
E. COLI
34
E. COLI
34
E. COLI
34
E. COLI
34
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
How Does This Compare?
COEUR D'ALENE (83814) has 385 recorded violations, including 29 health-based. 12 remain unresolved. Consider testing your tap water independently for added peace of mind.
Recommended Water Filters
Based on the contaminants detected in your area, these filter types may help improve your water quality.
Reverse Osmosis System
Highly effective at removing heavy metals, dissolved solids, and a wide range of contaminants. Recommended for homes with lead or arsenic concerns.
Targets:Lead, Copper, Arsenic, Mercury, Cadmium
Look for:NSF/ANSI 58 certified
Activated Carbon Filter
Excellent for removing chlorine, chloramine, and disinfection byproducts like THMs and HAAs. Available as pitcher filters, countertop, or under-sink units.
Targets:THMs, HAAs, Chlorine, Chloramine, Taste & Odor
Look for:NSF/ANSI 42 & 53 certified
UV Water Purifier
Uses ultraviolet light to neutralize bacteria, viruses, and parasites without chemicals. Ideal for homes with microbial contamination concerns.
Targets:E. coli, Coliform, Giardia, Cryptosporidium
Look for:NSF/ANSI 55 (Class A) certified
Always look for filters certified by NSF International for the specific contaminants you want to remove.